162 related articles for article (PubMed ID: 23300900)
1. A Gaussia luciferase cell-based system to assess the infection of cell culture- and serum-derived hepatitis C virus.
Koutsoudakis G; Pérez-del-Pulgar S; González P; Crespo G; Navasa M; Forns X
PLoS One; 2012; 7(12):e53254. PubMed ID: 23300900
[TBL] [Abstract][Full Text] [Related]
2. Development of NS3/4A protease-based reporter assay suitable for efficiently assessing hepatitis C virus infection.
Pan KL; Lee JC; Sung HW; Chang TY; Hsu JT
Antimicrob Agents Chemother; 2009 Nov; 53(11):4825-34. PubMed ID: 19721068
[TBL] [Abstract][Full Text] [Related]
3. Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.
Murayama A; Sugiyama N; Suzuki R; Moriyama M; Nakamura N; Mochizuki H; Wakita T; Kato T
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928005
[TBL] [Abstract][Full Text] [Related]
4. Intracytoplasmic stable expression of IgG1 antibody targeting NS3 helicase inhibits replication of highly efficient hepatitis C Virus 2a clone.
Chandra PK; Hazari S; Poat B; Gunduz F; Prabhu R; Liu G; Burioni R; Clementi M; Garry RF; Dash S
Virol J; 2010 Jun; 7():118. PubMed ID: 20529250
[TBL] [Abstract][Full Text] [Related]
5. Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons.
Laidlaw SM; Marukian S; Gilmore RH; Cashman SB; Nechyporuk-Zloy V; Rice CM; Dustin LB
Gastroenterology; 2017 Aug; 153(2):566-578.e5. PubMed ID: 28456632
[TBL] [Abstract][Full Text] [Related]
6. A reporter-based assay for identifying hepatitis C virus inhibitors based on subgenomic replicon cells.
Lee JC; Chang CF; Chi YH; Hwang DR; Hsu JT
J Virol Methods; 2004 Mar; 116(1):27-33. PubMed ID: 14715304
[TBL] [Abstract][Full Text] [Related]
7. Conditional Inducible Triple-Transgenic Mouse Model for Rapid Real-Time Detection of HCV NS3/4A Protease Activity.
Yao M; Lu X; Lei Y; Yang J; Zhao H; Qiao Q; Han P; Xu Z; Yin W
PLoS One; 2016; 11(3):e0150894. PubMed ID: 26943641
[TBL] [Abstract][Full Text] [Related]
8. In vitro infection of immortalized primary hepatocytes by HCV genotype 4a and inhibition of virus replication by cyclosporin.
El-Farrash MA; Aly HH; Watashi K; Hijikata M; Egawa H; Shimotohno K
Microbiol Immunol; 2007; 51(1):127-33. PubMed ID: 17237608
[TBL] [Abstract][Full Text] [Related]
9. A reporter cell line for rapid and sensitive evaluation of hepatitis C virus infectivity and replication.
Iro M; Witteveldt J; Angus AG; Woerz I; Kaul A; Bartenschlager R; Patel AH
Antiviral Res; 2009 Aug; 83(2):148-55. PubMed ID: 19397930
[TBL] [Abstract][Full Text] [Related]
10. Cell culture replication of a genotype 1b hepatitis C virus isolate cloned from a patient who underwent liver transplantation.
Koutsoudakis G; Perez-del-Pulgar S; Coto-Llerena M; Gonzalez P; Dragun J; Mensa L; Crespo G; Navasa M; Forns X
PLoS One; 2011; 6(8):e23587. PubMed ID: 21887279
[TBL] [Abstract][Full Text] [Related]
11. NS3 from Hepatitis C Virus Strain JFH-1 Is an Unusually Robust Helicase That Is Primed To Bind and Unwind Viral RNA.
Zhou T; Ren X; Adams RL; Pyle AM
J Virol; 2018 Jan; 92(1):. PubMed ID: 29070684
[TBL] [Abstract][Full Text] [Related]
12. Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.
Gottwein JM; Scheel TK; Hoegh AM; Lademann JB; Eugen-Olsen J; Lisby G; Bukh J
Gastroenterology; 2007 Nov; 133(5):1614-26. PubMed ID: 17983807
[TBL] [Abstract][Full Text] [Related]
13. Development of an intergenotypic hepatitis C virus (HCV) cell culture method to assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1 to 6.
Imhof I; Simmonds P
J Virol; 2010 May; 84(9):4597-610. PubMed ID: 20164226
[TBL] [Abstract][Full Text] [Related]
14. Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells.
Saeed M; Scheel TK; Gottwein JM; Marukian S; Dustin LB; Bukh J; Rice CM
Antimicrob Agents Chemother; 2012 Oct; 56(10):5365-73. PubMed ID: 22869572
[TBL] [Abstract][Full Text] [Related]
15. Establishment of serum derived infectivity coculture model for enhancement of hepatitis C virus replication in vitro.
Mounir M; Ibrahim MK; Dawood RM; Barakat AB; El Awady MK
Hum Antibodies; 2019; 27(3):185-191. PubMed ID: 30958341
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel small molecule inhibitors against the NS3/4A protease of hepatitis C virus genotype 4a.
El-Sayed SM; Ali MAM; El-Gendy BEM; Dandash SS; Issac Y; Saad R; Azab MM; Mohamed MR
Curr Pharm Des; 2018; 24(37):4484-4491. PubMed ID: 30501598
[TBL] [Abstract][Full Text] [Related]
17. Patient-derived hepatitis C virus and JFH-1 clones differ in their ability to infect human hepatoma cells and lymphocytes.
Sarhan MA; Chen AY; Russell RS; Michalak TI
J Gen Virol; 2012 Nov; 93(Pt 11):2399-2407. PubMed ID: 22855787
[TBL] [Abstract][Full Text] [Related]
18. Development of hepatitis C virus production reporter-assay systems using two different hepatoma cell lines.
Takeda M; Ikeda M; Ariumi Y; Wakita T; Kato N
J Gen Virol; 2012 Jul; 93(Pt 7):1422-1431. PubMed ID: 22456614
[TBL] [Abstract][Full Text] [Related]
19. Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization.
Scheel TK; Gottwein JM; Jensen TB; Prentoe JC; Hoegh AM; Alter HJ; Eugen-Olsen J; Bukh J
Proc Natl Acad Sci U S A; 2008 Jan; 105(3):997-1002. PubMed ID: 18195353
[TBL] [Abstract][Full Text] [Related]
20. In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
Yu M; Corsa AC; Xu S; Peng B; Gong R; Lee YJ; Chan K; Mo H; Delaney W; Cheng G
Antiviral Res; 2013 Nov; 100(2):439-45. PubMed ID: 24013001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
